• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用文献计量学评估罕见病的患病率。

Assessing rare diseases prevalence using literature quantification.

机构信息

Department of Medical Informatics, Hôpital Européen Georges Pompidou, AP-HP, 20 Rue Leblanc, 75015, Paris, France.

INSERM, Centre de Recherche des Cordeliers, UMRS 1138, Université de Paris, Université Sorbonne Paris Cité, Paris, France.

出版信息

Orphanet J Rare Dis. 2021 Mar 20;16(1):139. doi: 10.1186/s13023-020-01639-7.

DOI:10.1186/s13023-020-01639-7
PMID:33743790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7980535/
Abstract

INTRODUCTION

Estimating the prevalence of diseases is crucial for the organization of healthcare. The amount of literature on a rare pathology could help differentiate between rare and very rare diseases. The objective of this work was to evaluate to what extent the number of publications can be used to predict the prevalence of a given pathology.

METHODS

We queried Orphanet for the global prevalence class for all conditions for which it was available. For these pathologies, we cross-referenced the Orphanet, MeSH, and OMIM vocabularies to assess the number of publication available on Pubmed using three different query strategies (one proposed in the literature, and two built specifically for this study). We first studied the association of the number of publications obtained by each of these query strategies with the prevalence class, then their predictive ability.

RESULTS

Class prevalence was available for 3128 conditions, 2970 had a prevalence class < 1/1,000,000, 41 of 1-9/1,000,000, 84 of 1-9/100,000, and 33 of 1-9/10,000. We show a significant association and excellent predictive performance of the number of publication, with an AUC over 94% for the best query strategy.

CONCLUSION

Our study highlights the link and the excellent predictive performance of the number of publications on the prevalence of rare diseases provided by Orphanet.

摘要

简介

评估疾病的患病率对于医疗保健的组织至关重要。关于罕见病理学的文献数量有助于区分罕见病和极罕见病。这项工作的目的是评估文献数量在多大程度上可以用于预测特定病理学的患病率。

方法

我们在 Orphanet 上查询了所有可获得全球患病率类别的疾病。对于这些病理学,我们交叉参考了 Orphanet、MeSH 和 OMIM 词汇表,使用三种不同的查询策略(一种在文献中提出,两种专门为本研究构建)在 Pubmed 上评估可用的出版物数量。我们首先研究了每种查询策略获得的出版物数量与患病率类别的相关性,然后研究了它们的预测能力。

结果

3128 种疾病的患病率类别可获得,2970 种疾病的患病率<1/100 万,41 种疾病的患病率为 1-9/100 万,84 种疾病的患病率为 1-9/100,000,33 种疾病的患病率为 1-9/10,000。我们发现文献数量与患病率之间存在显著关联和极好的预测性能,最佳查询策略的 AUC 超过 94%。

结论

我们的研究强调了 Orphanet 提供的罕见疾病患病率与文献数量之间的联系和极好的预测性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d10/7980535/5e01a61245b7/13023_2020_1639_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d10/7980535/5e01a61245b7/13023_2020_1639_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d10/7980535/5e01a61245b7/13023_2020_1639_Fig1_HTML.jpg

相似文献

1
Assessing rare diseases prevalence using literature quantification.利用文献计量学评估罕见病的患病率。
Orphanet J Rare Dis. 2021 Mar 20;16(1):139. doi: 10.1186/s13023-020-01639-7.
2
Searching for rare diseases in PubMed: a blind comparison of Orphanet expert query and query based on terminological knowledge.在PubMed中搜索罕见病:Orphanet专家查询与基于术语知识的查询的盲法比较
BMC Med Inform Decis Mak. 2016 Aug 2;16:101. doi: 10.1186/s12911-016-0333-0.
3
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.估算罕见病的累计点患病率:对孤儿药数据库的分析。
Eur J Hum Genet. 2020 Feb;28(2):165-173. doi: 10.1038/s41431-019-0508-0. Epub 2019 Sep 16.
4
HPO2Vec+: Leveraging heterogeneous knowledge resources to enrich node embeddings for the Human Phenotype Ontology.HPO2Vec+:利用异构知识资源丰富人类表型本体的节点嵌入。
J Biomed Inform. 2019 Aug;96:103246. doi: 10.1016/j.jbi.2019.103246. Epub 2019 Jun 27.
5
Healthcare burden of rare diseases in Hong Kong - adopting ORPHAcodes in ICD-10 based healthcare administrative datasets.香港罕见病的医疗负担 - 在基于 ICD-10 的医疗管理数据集采用 ORPHAcodes。
Orphanet J Rare Dis. 2018 Aug 28;13(1):147. doi: 10.1186/s13023-018-0892-5.
6
Prevalence of zebras in general practice: data from the Continuous Morbidity Registration Nijmegen.全科医疗中斑马病的患病率:来自奈梅亨连续发病登记的数据。
Eur J Gen Pract. 2008;14 Suppl 1:44-6. doi: 10.1080/13814780802436176.
7
[Orphanet and its consortium: where to find expert-validated information on rare diseases].[欧洲罕见病组织及其联盟:获取罕见病专家验证信息的途径]
Rev Neurol (Paris). 2013 Feb;169 Suppl 1:S3-8. doi: 10.1016/S0035-3787(13)70052-3.
8
Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users.健康信息系统中罕见病的表示:Orphanet 方法服务广泛的终端用户。
Hum Mutat. 2012 May;33(5):803-8. doi: 10.1002/humu.22078. Epub 2012 Apr 6.
9
[Use of a directory of specialized services and guidance in the healthcare system: the example of the Orphanet database for rare diseases].[医疗保健系统中专业服务目录及指南的使用:以罕见病Orphanet数据库为例]
Rev Epidemiol Sante Publique. 2006 Feb;54(1):41-53. doi: 10.1016/s0398-7620(06)76693-7.
10
Orthodontically Relevant Manifestations in People with Rare Diseases.罕见病患者的正畸相关表现。
Med Princ Pract. 2019;28(3):216-221. doi: 10.1159/000497437. Epub 2019 Feb 4.

引用本文的文献

1
Scientific Evidence Based Knowledge Graph in Rare Diseases.罕见病领域基于科学证据的知识图谱
Proceedings (IEEE Int Conf Bioinformatics Biomed). 2021 Dec;2021:2614-2617. doi: 10.1109/bibm52615.2021.9669645. Epub 2022 Jan 14.
2
Optimizing gene prioritization for clinical diagnosis of metabolic genetic disorders.优化代谢性遗传疾病临床诊断中的基因优先级排序
PLoS One. 2025 Aug 29;20(8):e0331038. doi: 10.1371/journal.pone.0331038. eCollection 2025.
3
Children and Adolescents with Mucopolysaccharidosis and Osteogenesis Imperfecta: The Dentistry on the Multiprofessional Team.
患有黏多糖贮积症和成骨不全症的儿童和青少年:多专业团队中的牙科治疗
J Pers Med. 2025 Jul 18;15(7):323. doi: 10.3390/jpm15070323.
4
A Study on the Current Situation and Factors Influencing the General Practice Ability of Clinical Undergraduate Students in China.中国临床本科医学生全科医疗能力现状及影响因素研究
Healthcare (Basel). 2025 Mar 26;13(7):733. doi: 10.3390/healthcare13070733.
5
Classification and epidemiologic analysis of 86 diseases in .关于……中86种疾病的分类与流行病学分析 (你提供的原文不完整,这里只是按照现有内容翻译)
Intractable Rare Dis Res. 2024 Nov 30;13(4):213-226. doi: 10.5582/irdr.2024.01061.
6
An estimation of global genetic prevalence of PLA2G6-associated neurodegeneration.PLA2G6 相关神经退行性疾病的全球遗传患病率估计。
Orphanet J Rare Dis. 2024 Oct 18;19(1):388. doi: 10.1186/s13023-024-03275-x.
7
Oral Problems in Brazilian Individuals with Rare Genetic Diseases That Affect Skeletal Development.巴西患有影响骨骼发育的罕见遗传疾病患者的口腔问题。
Int J Environ Res Public Health. 2024 Sep 18;21(9):1227. doi: 10.3390/ijerph21091227.
8
Secondary use of patient data within decentralized studies using the example of rare diseases in Germany: A data scientist's exploration of process and lessons learned.以德国罕见病为例,探讨分散式研究中患者数据的二次利用:一位数据科学家对流程及经验教训的探索。
Digit Health. 2024 Aug 10;10:20552076241265219. doi: 10.1177/20552076241265219. eCollection 2024 Jan-Dec.
9
Economic Rationality in Decision-Making Regarding Newborn Screening: A Case Study in Quebec.新生儿筛查决策中的经济合理性:魁北克的一个案例研究
Int J Neonatal Screen. 2024 May 13;10(2):36. doi: 10.3390/ijns10020036.
10
Qualified placebo for trials of herbal medicine treatment in rare diseases? A cross-sectional analysis.合格的安慰剂用于罕见病草药治疗试验?一项横断面分析。
Orphanet J Rare Dis. 2023 Nov 30;18(1):373. doi: 10.1186/s13023-023-02987-w.